Conmed (CNMD) Tops Q2 EPS by 88c

Conmed (NASDAQ: CNMD) reported Q2 EPS of ($0.07), $0.88 better than the analyst estimate of ($0.95). Revenue for the quarter came in at $157.8 million versus the consensus estimate of $126.59 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c